Tuberculous prostatic abscess with prostatorectal fistula after intravesical bacillus Calmette-Guérin immunotherapy

10Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Intravesical bacillus Calmette-Guérin (BCG) immunotherapy is a common treatment modality for bladder cancer after transurethral resection of a bladder tumor. This therapy is generally safe, and development of a prostatic abscess with a prostatorectal fistula after intravesical BCG immunotherapy is a very rare complication. This finding was incidentally obtained by the authors, who examined a patient with colonoscopy for evaluation of abdominal pain. The patient was successfully treated with antitubercular drugs. To the authors’ knowledge, this is the first report of a patient with a tuberculous prostatic abscess with prostatorectal fistula after BCG immunotherapy in South Korea.

Author supplied keywords

Cite

CITATION STYLE

APA

Eom, J. H., Yoon, J. H., Lee, S. W., Kim, H. S., Park, T. Y., Bang, C. S., … Kim, D. J. (2016). Tuberculous prostatic abscess with prostatorectal fistula after intravesical bacillus Calmette-Guérin immunotherapy. Clinical Endoscopy, 49(5), 488–491. https://doi.org/10.5946/ce.2015.145

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free